Potential Benefits of Microdosing GLP-1s By using smaller, carefully measured doses of semaglutide or tirzepatide, patients may experience benefits in multiple areas of health, which may include the following: Lower Cholesterol Microdosing GLP-1s may help improve cholesterol profiles by supporting healthier metabolic function
1 The LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsA Long-Term Evaluation), a large double-blind, placebo-controlled trial, recently demonstrated that liraglutide added to standard therapy for a relatively short period of time (3.5-5 years) had a significant reduction in cardiovas-cular events and mortality compared to placebo in high-risk patients (hazard ratio [HR], 0.87
For patients on GLP-1 medications, AI can flag elevated risks for specific complications, prompting clinicians to adjust therapy or order targeted tests before symptoms appear
These extended restorative applications make openings for pharmaceutical companies to create comprehensive item portfolios tending to numerous illness states
BMJ Open 8 , e023830 (2018)
While early research shows that very little (if any) of the medication passes into breast milk, theres still a lot we dont know
